{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:59:48Z","timestamp":1790553588601,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.semnephrol.2023.151467","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T14:15:09Z","timestamp":1704809709000},"page":"151467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Strategies to Prevent Infections in Dialysis Patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Daniela","family":"Ponce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat Alp","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2023.151467_bib0001","unstructured":"United States Renal Data System. 2022 Annual data report. End stage renal disease. Chapter 6: mortality. Accessed September 02, 2022. https:\/\/usrds-adr.niddk.nih.gov\/2022\/end-stage-renal-disease\/6-mortality"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0002","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1053\/ajkd.2001.v38.a28251","article-title":"Survival, mortality, & causes of death","volume":"38","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0003","unstructured":"United States Renal Data System. USRDS 2018 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018. https:\/\/www.usrds.org\/2014\/view"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0004","unstructured":"United States Renal Data System. USRDS 2020 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; 2020."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0005","unstructured":"United States Renal Data System. 2022 Annual data report. End stage renal disease. Chapter 5: hospitalization. https:\/\/usrds-adr.niddk.nih.gov\/2022\/end-stage-renal-disease\/5-hospitalization"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0006","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","article-title":"Infectious complications in chronic kidney disease","volume":"13","author":"Naqvi","year":"2006","journal-title":"Adv Chronic Kidney Dis."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.ajkd.2011.07.012","article-title":"The risk of infection-related hospitalization with decreased kidney function","volume":"59","author":"Dalrymple","year":"2012","journal-title":"Am J Kidney Dis."},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151467_bib0008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000444826","article-title":"UK Renal Registry 18th Annual Report. Chapter 12: epidemiology of reported infections amongst patients receiving dialysis for established renal failure in England 2013 to 2014: a Joint Report from Public Health England and the UK Renal Registry","volume":"132","author":"Evans","year":"2016","journal-title":"Nephron."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0009","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","article-title":"Clinical epidemiology of infectious disease among patients with chronic kidney disease","volume":"23","author":"Ishigami","year":"2019","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2016.09.018","article-title":"CKD and risk for hospitalization with infection: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"69","author":"Ishigami","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0011","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0012","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.ASN.0000119144.95922.C4","article-title":"Septicemia in the United States dialysis population, 1991 to 1999","volume":"15","author":"Foley","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0013","first-page":"27","article-title":"Drug resistant organisms and their implications for the outpatient dialysis setting","volume":"11","author":"Alexander","year":"1997","journal-title":"Nephrol News Issues."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ajkd.2014.10.003","article-title":"Multidrug-resistant organisms within the dialysis population: a potentially preventable perfect storm","volume":"65","author":"Calfee","year":"2015","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","article-title":"National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151467_bib0016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/sdi.12117","article-title":"Prevention and treatment of hemodialysis-related bloodstream infections","volume":"26","author":"Camins","year":"2013","journal-title":"Semin Dial"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151467_bib0017","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0018","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncpneph0447","article-title":"Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management","volume":"3","author":"Katneni","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151467_bib0019","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1523-1755.2005.00364.x","article-title":"Bacterial infections in hemodialysis patients: pathogenesis and prevention","volume":"67","author":"Jaber","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1525-139X.2006.00143.x","article-title":"Long-term management of the tunneled venous catheter","volume":"19","author":"Liangos","year":"2006","journal-title":"Semin Dial"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151467_bib0021","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0022","first-page":"S1","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, vascular access","volume":"48","year":"2006","journal-title":"Am J Kidney Dis."},{"issue":"RR-10","key":"10.1016\/j.semnephrol.2023.151467_bib0023","first-page":"1","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"51","author":"O\u2019Grady","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0024","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ki.2010.471","article-title":"Prevention and management of catheter-related infection in hemodialysis patients","volume":"79","author":"Lok","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.tvir.2016.11.001","article-title":"Vascular access guidelines: summary, rationale and controversies","volume":"20","author":"Sequeira","year":"2017","journal-title":"Tech Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0027","unstructured":"Elias RM. Tratamento da infeccao de cateter de hemodialis. Cruz J, et al. eds. Atualidades Em Nefrologia 10. Sarvier; 2008:361-366 [in Portuguese]."},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0028","first-page":"1","article-title":"Epidemiology and outcome of exit site infection catheter related among patients from a Brazilian haemodialysis unit","volume":"3","author":"Goulart","year":"2016","journal-title":"J Urol Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10156-002-0184-8","article-title":"A prospective study of hemodialysis access related bacterial infections","volume":"8","author":"Saeed Abdulrahman","year":"2002","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ndt\/gfg581","article-title":"Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use","volume":"19","author":"Weijmere","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1525-1594.2005.29067.x","article-title":"Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients","volume":"29","author":"Develter","year":"2005","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajic.2003.05.007","article-title":"Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients","volume":"32","author":"Taylor","year":"2004","journal-title":"Am J Infect Control"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151467_bib0033","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/cid\/cir138","article-title":"Summary of recommendations: guidelines for the prevention of intravascular catheter related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151467_bib0034","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2215\/CJN.03900411","article-title":"The spectrum of infections in catheter-dependent hemodialysis patients","volume":"6","author":"Al-Solaiman","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrneph.2011.28","article-title":"Prevention of catheter-related bloodstream infection in patients on hemodialysis","volume":"7","author":"Betjes","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151467_bib0036","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-136-11-200206040-00007","article-title":"Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis","volume":"136","author":"Chaiyakunapruk","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0037","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/QCO.0b013e3282ffd6e0","article-title":"Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review","volume":"21","author":"Gilbert","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.281.3.261","article-title":"Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infections: a meta-analysis","volume":"281","author":"Veenstra","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151467_bib0039","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/17.10.1802","article-title":"A randomised controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters","volume":"17","author":"Johnson","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151467_bib0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-148-8-200804150-00004","article-title":"Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections","volume":"148","author":"James","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0041","article-title":"Interventions for preventing infectious complications in haemodialysis patients with central venous catheters","author":"McCann","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0042","unstructured":"Centers for Disease Control and Prevention. Dialysis safety: core interventions. Accessed May 9, 2023. https:\/\/www.cdc.gov\/dialysis\/preventiontools\/core-interventions.html"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151467_bib0043","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2215\/CJN.04700514","article-title":"Reducing catheter-related infections in hemodialysis patients","volume":"9","author":"Landry","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0044","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.ki.5000012","article-title":"Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomised clinical trial","volume":"69","author":"Kim","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0045","first-page":"239","article-title":"Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin","volume":"18","author":"Al-Hwiesh","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0046","first-page":"303","article-title":"Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime","volume":"16","author":"Mortazavi","year":"2011","journal-title":"J Res Med Sci"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0047","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11255-012-0339-1","article-title":"Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin","volume":"45","author":"Silva","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0048","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ndt\/gfm847","article-title":"Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solutions: a meta-analysis of prospective randomised trials","volume":"23","author":"Labriola","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0049","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2007.10.038","article-title":"A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection","volume":"51","author":"Jaffer","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/588667","article-title":"Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomised, controlled trials","volume":"47","author":"Yahav","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2009.12.017","article-title":"Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials","volume":"75","author":"Snaterse","year":"2010","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0052","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.ajkd.2013.08.016","article-title":"Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomised controlled trial","volume":"63","author":"Zhao","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0053","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1097\/MJT.0b013e31828d4610","article-title":"A taurolidine-citrate heparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients","volume":"23","author":"Zwiech","year":"2016","journal-title":"Am J Ther"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151467_bib0054","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/jac\/dku281","volume":"69","author":"Luther","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151467_bib0055","doi-asserted-by":"crossref","first-page":"e79417","DOI":"10.1371\/journal.pone.0079417","article-title":"Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151467_bib0056","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000360271","article-title":"Preventing catheter-related bacteremia with taurolidine citrate catheter locks: a systematic review and meta-analysis","volume":"37","author":"Liu","year":"2014","journal-title":"Blood Purif"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151467_bib0057","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/cid\/ciu671","article-title":"Antimicrobial lock solutions as a method to prevent central line \u2013 associated bloodstream infections: a meta-analysis of randomised controlled trials","volume":"59","author":"Zacharioudakis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151467_bib0058","article-title":"Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease (review)","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151467_bib0059","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11255-016-1490-x","article-title":"Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0077","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2215\/CJN.06050614","article-title":"Infection prevention and the medical director: uncharted territory","volume":"10","author":"Kapoian","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3747\/pdi.2014.00007","article-title":"Peritonitis rates of the past thirty years: from improvement to stagnation","volume":"34","author":"Szeto","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0061","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3747\/pdi.2013.00275","article-title":"32 Years\u2019 experience of peritoneal dialysis\u2013related peritonitis in a university hospital","volume":"34","author":"van Esch","year":"2014","journal-title":"Perit Dial Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151467_bib0062","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2215\/CJN.11431210","article-title":"Pecoits-Filho R, on behalf of the Brazilian Peritoneal Dialysis Multicenter Study BRAZPD Group. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis Study (BRAZPD) Patients","volume":"6","author":"Martin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151467_bib0063","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2215\/CJN.09280913","article-title":"Peritoneal dialysis\u2013related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center","volume":"9","author":"Camargo","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0064","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2334-9-212","article-title":"The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients","volume":"9","author":"Barretti","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151467_bib0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/mmy\/myw030","article-title":"Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents","volume":"4","author":"Giacobino","year":"2016","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0066","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151467_bib0067","article-title":"Automated peritoneal dialysis is associated with better survival rates compared to continuous ambulatory peritoneal dialysis: a propensity score matching analysis","volume":"10","author":"Beduschi G de","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151467_bib0068","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.09730913","article-title":"The association between peritoneal dialysis modality and peritonitis","volume":"9","author":"Lan","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151467_bib0069","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12882-017-0588-4","article-title":"The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients","volume":"18","author":"Ye","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151467_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ndt\/gfu286","article-title":"Impact of patient training patterns on peritonitis rates in a large national cohort study","volume":"30","author":"Figueiredo","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151467_bib0071","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/JCM.03378-15","article-title":"Matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry accelerates pathogen identification and may confer benefit in the outcome of peritoneal dialysis-related peritonitis","volume":"54","author":"Lin","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0072","first-page":"154","article-title":"Vancomycin: the tale of the vanquisher and the pyrrhic victory","volume":"34","author":"De Vriese","year":"2014","journal-title":"Perit Dial Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151467_bib0073","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3747\/pdi.2012.00233","article-title":"Microbiology and outcomes of peritonitis in northern India","volume":"34","author":"Prasad","year":"2016","journal-title":"Perit Dial Int"},{"issue":"14","key":"10.1016\/j.semnephrol.2023.151467_bib0074","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/1471-2334-14-445","article-title":"Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis","author":"Barretti","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151467_bib0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ckj\/sfw059","article-title":"Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis","volume":"9","author":"Szeto","year":"2016","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.semnephrol.2023.151467_bib0076","unstructured":"Centers for Disease Control and Prevention. Central venous catheter hub cleaning prior to accessing. 2016. Accessed August 7, 2023. https:\/\/www.cdc.gov\/dialysis\/PDFs\/collaborative\/Hemodialysis-Central-Venous-Catheter-STH-Protocol.pdfub-Cleaning-FINAL-3-12.pdf"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T22:22:06Z","timestamp":1748384526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0270929523001778"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151467","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to Prevent Infections in Dialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151467"}}